Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Catalyst Watch: Alphabet Earnings, McGraw Hill IPO, Trump Talks AI, and More Robotaxi Buzz
HOOKIPA Pharma to Delist From Nasdaq and Liquidate Following Gilead Asset Sale
Merck KGaA Gets EU Nod for Ezmekly
Dividend Roundup: Citigroup, Coca-Cola, Caterpillar, Pfizer, and More
Viatris Down on Late-stage Trial Setback for Eye Disorder Therapy
Bristol Myers Fails in Late-stage Trial for Merck-partnered Anemia Therapy in Blood Cancer